Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Rating)'s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.74 and traded as low as $0.60. Northwest Biotherapeutics shares last traded at $0.60, with a volume of 902,059 shares.
Northwest Biotherapeutics Trading Down 4.6 %
The firm has a 50-day moving average of $0.67 and a 200 day moving average of $0.74. The stock has a market capitalization of $644.77 million, a price-to-earnings ratio of -5.96 and a beta of -0.03.
Northwest Biotherapeutics Company Profile
(Get Rating)
Northwest Biotherapeutics, Inc is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The company was founded by Alton L.
Featured Stories
- Get a free copy of the StockNews.com research report on Northwest Biotherapeutics (NWBO)
- Dave & Buster's Rebound Could Score for Investors
- Cal-Maine: Is it Time to Chase this Stock Higher?
- The Most Important Warren Buffett Stock for Investors: His Own
- Three Mid Caps Wall Street Sees Doubling Within 12 Months
- It's No Stretch: Lululemon Could Break Out of its Range
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.